Ostatní
Návod 
Novo Nordisk A/S
NVO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
203.1B
Obrat
308B
Zisk
102B
Aktiva
482B
Dluh
99B
ROE
0%
ROA
0%
PE
2
PS
1
Cena 1R
43-94
⌀ Cena
59.01
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-02-2026
Poslední dividenda
30-03-2026
Profil
Novo Nordisk A/S, zdravotní společnost, se zabývá výzkumem, vývojem, výrobou a uváděním farmaceutických výrobků na trh po celém světě. Působí ve dvou segmentech, diabetes a obezita péče, a Biopharm. Segment Diabetes and Obesity care poskytuje produkty v oblastech inzulínu, GLP-1 a souvisejících systémů podávání, perorálních antidiabetik, obezity a dalších chronických onemocnění. Segment Biofarmak nabízí produkty v oblasti hemofilie, poruch růstu a hormonální substituční terapie. Společnost uzavřela se společností Gilead Sciences, Inc. Novo Nordisk A/S spolupráci s Lumen Bioscience, Inc. na výzkumu strategií pro poskytování orální biologie pro kardiometabolické onemocnění. Společnost byla založena v roce 1923 a sídlí v Bagsvaerdu v Dánsku.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
77406
Založení
1981-04-30
Podobné společnosti
$ 86.23
- $ 0.05
$ 126.72
+ $ 0.37
$ 125.44
- $ 0.93
$ 86.08
+ $ 1.50
$ 117.95
- $ 0.89
$ 24.16
- $ 0.28
$ 574.83
+ $ 2.42
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 308.4 | 297.2 | 290.4 | 232.3 | 177.0 | 140.8 | 126.9 | 122.0 | 111.8 | 111.7 | 111.8 | 107.9 | 88.8 | 83.6 | 78.0 | 66.3 | 60.8 | |
| Cost of Revenues | 58.7 | 58.4 | 44.5 | 35.8 | 28.4 | 23.7 | 20.9 | 20.1 | 17.6 | 17.6 | 17.2 | 16.2 | 14.6 | 14.1 | 13.5 | 12.6 | 11.7 | |
| Gross Profit | 249.7 | 238.8 | 245.9 | 196.5 | 148.5 | 117.1 | 106.0 | 101.9 | 94.2 | 94.1 | 94.6 | 91.7 | 74.2 | 69.4 | 64.6 | 53.8 | 49.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 78.4 | 75.0 | 76.9 | 78.1 | 85.7 | 71.3 | 68.1 | 65.3 | 65.9 | 58.7 | |
| Cost of Revenues | 15.0 | 17.9 | 12.8 | 12.9 | 13.0 | 11.3 | 10.3 | 9.9 | 10.0 | 9.7 | |
| Gross Profit | 63.4 | 57.1 | 64.0 | 65.2 | 72.7 | 60.0 | 57.8 | 55.4 | 55.8 | 49.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 32.4 | 24.0 | 17.8 | 15.5 | 14.2 | 14.8 | 14.0 | 14.6 | 13.6 | 13.8 | 11.7 | 10.9 | 9.6 | 9.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 61.6 | 50.7 | 41.1 | 36.9 | 35.8 | 33.3 | 32.1 | 32.3 | 32.2 | 26.8 | 26.9 | 24.9 | 22.2 | 21.9 | |
| Depreciation & Amortization | 17.4 | 14.1 | 8.5 | 9.4 | 7.2 | 8.9 | 6.1 | 5.3 | 3.9 | 3.2 | 3.2 | 3.0 | 3.4 | 2.8 | 2.7 | 0.0 | 2.5 | |
| Total Operating Expenses | 122.2 | 108.9 | 117.5 | 93.9 | 73.7 | 58.5 | 51.9 | 49.5 | 47.0 | 45.1 | 46.2 | 42.3 | 39.8 | 37.9 | 35.1 | 31.9 | 31.5 | |
| Operating Income | 127.5 | 129.8 | 128.3 | 102.6 | 74.8 | 58.6 | 54.1 | 52.5 | 47.2 | 49.0 | 48.4 | 49.4 | 34.5 | 31.5 | 29.5 | 22.4 | 18.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | 8.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 18.6 | 14.1 | ||
| Depreciation & Amortization | 5.5 | 3.2 | 4.8 | 3.8 | 5.4 | 2.2 | 8.8 | 2.9 | 3.0 | 2.5 | ||
| Total Operating Expenses | 31.8 | 33.4 | 30.6 | 26.4 | 35.9 | 26.2 | 31.9 | 23.6 | 29.1 | 22.1 | ||
| Operating Income | 31.6 | 23.7 | 33.4 | 38.8 | 36.7 | 33.8 | 25.9 | 31.8 | 26.8 | 26.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.3 | 9.3 | 1.8 | 1.1 | 0.2 | 2.9 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.5 | 0.4 | |
| Interest Expense | 6.5 | 6.5 | 1.6 | 0.5 | 0.4 | 2.5 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 6.0 | 0.6 | 0.1 | 0.1 | 1.0 | 2.1 | |
| Other Expense | 2.7 | -4.3 | -1.1 | 2.1 | -5.7 | 0.4 | -1.0 | -3.9 | 0.5 | -0.2 | -0.5 | -5.9 | -0.3 | 0.3 | -1.6 | 0.5 | 1.1 | |
| IBT | 130.2 | 125.5 | 127.2 | 104.7 | 69.1 | 59.1 | 53.1 | 48.6 | 47.6 | 48.7 | 47.8 | 43.5 | 34.1 | 32.5 | 27.8 | 21.9 | 18.3 | |
| Income Tax Expense | 28.0 | 27.0 | 26.2 | 21.0 | 13.5 | 11.3 | 11.0 | 9.6 | 9.0 | 10.6 | 9.9 | 8.6 | 7.6 | 7.4 | 6.4 | 4.8 | 3.9 | |
| Net Income | 102.2 | 98.5 | 101.0 | 83.7 | 55.5 | 47.8 | 42.1 | 39.0 | 38.6 | 38.1 | 37.9 | 34.9 | 26.5 | 25.2 | 21.4 | 17.1 | 14.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -4.8 | 5.3 | 5.3 | 3.4 | 0.0 | 1.4 | 1.0 | 2.1 | 0.0 | 3.3 | ||
| Interest Expense | -8.6 | 5.0 | 5.0 | 5.2 | 0.0 | 0.8 | 1.6 | 2.1 | 0.0 | 2.2 | ||
| Other Expense | 2.3 | 1.8 | 0.4 | -1.8 | -1.2 | 0.6 | -0.6 | 0.1 | 0.9 | 1.2 | ||
| IBT | 33.9 | 25.5 | 33.8 | 37.0 | 35.6 | 34.4 | 25.3 | 31.9 | 27.6 | 28.1 | ||
| Income Tax Expense | 7.2 | 5.5 | 7.3 | 8.0 | 7.3 | 7.1 | 5.3 | 6.5 | 5.7 | 5.6 | ||
| Net Income | 26.7 | 20.0 | 26.5 | 29.0 | 28.2 | 27.3 | 20.1 | 25.4 | 22.0 | 22.5 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $18.62 | $12.26 | $10.40 | $9.03 | $8.20 | $7.98 | $7.71 | $7.50 | $13.56 | $10.10 | $9.40 | $7.82 | $6.05 | $4.96 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $18.62 | $12.22 | $10.37 | $9.00 | $8.19 | $7.97 | $7.70 | $7.48 | $13.52 | $10.07 | $9.35 | $7.77 | $6.00 | $4.92 | |
| Shares Outstanding | 4.4 | 4.4 | 4.5 | 4.5 | 4.5 | 4.6 | 4.7 | 4.7 | 4.8 | 4.9 | 5.1 | 2.6 | 2.6 | 2.7 | 2.7 | 2.8 | 2.9 | |
| Diluted Shares Outstanding | 4.4 | 4.4 | 4.5 | 4.5 | 4.5 | 4.6 | 4.7 | 4.8 | 4.8 | 5.0 | 5.1 | 2.6 | 2.6 | 2.7 | 2.8 | 2.9 | 2.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.92 | $5.02 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.91 | $5.01 | ||
| Shares Outstanding | 4.4 | 4.4 | 4.4 | 4.4 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | ||
| Diluted Shares Outstanding | 4.4 | 4.4 | 4.4 | 4.4 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 52.8 | 15.7 | 14.4 | 12.7 | 10.7 | 12.8 | 15.5 | 15.6 | 18.9 | 18.7 | 16.9 | 14.4 | 10.7 | 11.6 | 13.4 | 12.0 | |
| Short Term Investments | 9.8 | 10.7 | 15.8 | 10.9 | 6.8 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 3.5 | 1.5 | 3.7 | 4.6 | 4.1 | 4.0 | |
| Total Cash & ST Investments | 62.7 | 26.3 | 30.2 | 23.6 | 17.5 | 12.8 | 15.5 | 15.6 | 18.9 | 20.7 | 20.5 | 15.9 | 14.5 | 16.1 | 17.5 | 16.1 | |
| Accounts Receivable | 66.5 | 87.4 | 75.3 | 57.5 | 46.8 | 32.2 | 29.2 | 26.9 | 23.6 | 24.2 | 21.6 | 19.0 | 15.2 | 13.6 | 12.6 | 9.2 | |
| Inventory | 36.4 | 40.8 | 31.8 | 24.4 | 19.6 | 18.5 | 17.6 | 16.3 | 15.4 | 14.3 | 12.8 | 11.4 | 9.6 | 9.5 | 9.4 | 9.7 | |
| Other Current Assets | 12.0 | 6.3 | 2.3 | 2.7 | 1.7 | 2.3 | 0.2 | 0.2 | 2.3 | 0.5 | 0.3 | 1.5 | 2.9 | 0.9 | 0.0 | 2.4 | |
| Total Current Assets | 177.5 | 160.9 | 139.6 | 108.2 | 85.6 | 65.8 | 62.5 | 59.1 | 60.1 | 59.8 | 55.1 | 46.3 | 42.1 | 40.2 | 39.6 | 37.3 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 18.4 | 38.9 | 15.7 | 57.0 | 52.8 | 6.3 | 14.4 | 30.1 | 21.6 | 14.9 | |
| Short Term Investments | 0.5 | 2.6 | 10.7 | 17.9 | 9.8 | 3.0 | 15.8 | 17.5 | 14.8 | 12.8 | |
| Total Cash & ST Investments | 18.9 | 41.6 | 26.3 | 74.9 | 62.7 | 9.3 | 30.2 | 47.6 | 36.4 | 27.8 | |
| Accounts Receivable | 85.8 | 86.4 | 87.4 | 79.6 | 76.1 | 71.8 | 75.3 | 62.0 | 70.5 | 57.9 | |
| Inventory | 45.7 | 42.9 | 40.8 | 37.9 | 36.4 | 33.6 | 31.8 | 29.5 | 28.0 | 25.6 | |
| Other Current Assets | 12.3 | 3.6 | 6.3 | 2.7 | 2.4 | 1.8 | 2.3 | 3.1 | 2.6 | 2.6 | |
| Total Current Assets | 162.7 | 174.4 | 160.9 | 195.2 | 177.5 | 116.4 | 139.6 | 142.2 | 137.6 | 113.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 110.0 | 162.5 | 91.0 | 66.7 | 55.4 | 50.3 | 50.6 | 41.9 | 35.2 | 30.2 | 25.5 | 23.1 | 21.9 | 21.5 | 20.9 | 20.5 | |
| Goodwill | 0.0 | 20.1 | 4.5 | 5.1 | 4.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Intangible Assets | 55.5 | 91.0 | 55.9 | 46.3 | 38.8 | 20.7 | 5.8 | 5.1 | 3.3 | 2.7 | 2.2 | 1.4 | 1.6 | 1.5 | 1.5 | 1.5 | |
| Long-Term Investments | 1.7 | 2.7 | 1.7 | 1.3 | 1.4 | 1.6 | 1.8 | 1.8 | 1.8 | 2.2 | 2.2 | 0.9 | 0.6 | 0.2 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.2 | 4.0 | 21.8 | 0.2 | 0.3 | 0.7 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.3 | |
| Total Long-Term Assets | 191.9 | 304.9 | 174.8 | 133.1 | 108.9 | 79.1 | 63.2 | 51.7 | 42.3 | 37.8 | 36.7 | 30.8 | 28.3 | 25.5 | 25.1 | 24.1 | |
| Total Assets | 369.4 | 465.8 | 314.5 | 241.3 | 194.5 | 144.9 | 125.6 | 110.8 | 102.4 | 97.5 | 91.8 | 77.1 | 70.3 | 65.7 | 64.7 | 61.4 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 180.8 | 172.4 | 162.5 | 119.8 | 110.0 | 98.2 | 91.0 | 81.5 | 75.0 | 70.0 | |
| Goodwill | 0.0 | 0.0 | 20.1 | 0.0 | 0.0 | 0.0 | 4.5 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 107.9 | 109.4 | 91.0 | 54.5 | 55.5 | 59.6 | 55.9 | 55.7 | 50.7 | 50.5 | |
| Long-Term Investments | 2.6 | 2.7 | 2.7 | 2.0 | 1.7 | 1.7 | 1.7 | 1.5 | 1.5 | 1.2 | |
| Other Long-Term Assets | 4.4 | 4.0 | 4.0 | 2.5 | 2.2 | 2.0 | 1.4 | 0.4 | 0.3 | 0.3 | |
| Total Long-Term Assets | 319.4 | 314.8 | 304.9 | 202.3 | 191.9 | 182.5 | 174.8 | 157.9 | 143.2 | 136.1 | |
| Total Assets | 482.2 | 489.2 | 465.8 | 397.4 | 369.4 | 298.9 | 314.5 | 300.1 | 280.8 | 250.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 29.8 | 28.8 | 25.6 | 15.6 | 8.9 | 5.7 | 6.4 | 6.8 | 5.6 | 6.0 | 4.9 | 5.0 | 4.1 | 3.9 | 3.3 | 2.9 | |
| Short-Term Debt | 5.5 | 13.1 | 6.5 | 1.5 | 13.7 | 7.5 | 1.5 | 0.5 | 1.7 | 0.2 | 1.1 | 0.7 | 0.2 | 0.5 | 0.4 | 1.7 | |
| Other Current Liabilities | 146.8 | 165.9 | 130.5 | 103.9 | 21.8 | 18.4 | 15.8 | 41.9 | 0.3 | 2.6 | 14.0 | 13.7 | 16.9 | 0.0 | 10.0 | 8.0 | |
| Current Liabilities | 187.9 | 217.5 | 169.7 | 120.9 | 99.5 | 70.3 | 59.0 | 54.2 | 47.1 | 47.4 | 40.9 | 33.7 | 24.2 | 21.6 | 20.8 | 18.5 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 28.2 | 19.6 | 28.8 | 24.1 | 29.8 | 13.0 | 25.6 | 20.1 | 17.8 | 10.1 | |
| Short-Term Debt | 12.0 | 22.4 | 13.1 | 5.5 | 5.5 | 10.2 | 6.5 | 6.6 | 6.3 | 1.3 | |
| Other Current Liabilities | 150.4 | 178.6 | 165.9 | 164.1 | 146.8 | 136.5 | 22.9 | 16.4 | 14.4 | 114.6 | |
| Current Liabilities | 207.5 | 236.1 | 217.5 | 208.4 | 187.9 | 165.6 | 169.7 | 172.6 | 156.6 | 132.0 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 51.6 | 89.7 | 20.5 | 24.3 | 13.0 | 2.9 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | |
| Capital Leases | 0.0 | 6.8 | 5.7 | 4.5 | 4.1 | 3.7 | 3.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 9.0 | 5.4 | 0.0 | 7.1 | 5.3 | 2.5 | 0.1 | 0.1 | 0.8 | 0.0 | 0.0 | 0.0 | 0.7 | 0.7 | 3.2 | 2.9 | |
| Total Liabilities | 256.9 | 322.3 | 207.9 | 157.8 | 123.8 | 81.6 | 68.0 | 58.9 | 52.5 | 52.3 | 44.8 | 36.8 | 27.8 | 25.0 | 27.3 | 24.4 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 87.3 | 96.3 | 89.7 | 51.5 | 51.6 | 16.8 | 20.5 | 19.9 | 19.4 | 24.3 | |
| Capital Leases | 0.0 | 0.0 | 6.8 | 0.0 | 0.0 | 0.0 | 5.7 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 9.8 | 8.7 | 5.4 | 8.7 | 9.0 | 9.7 | 10.2 | 7.9 | 7.6 | 7.9 | |
| Total Liabilities | 314.1 | 350.6 | 322.3 | 276.9 | 256.9 | 200.0 | 207.9 | 207.1 | 190.3 | 170.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Retained Earnings | 112.2 | 144.4 | 104.8 | 80.6 | 72.0 | 63.8 | 57.8 | 53.4 | 49.0 | 46.1 | 46.8 | 41.3 | 41.1 | 39.0 | 37.1 | 36.1 | |
| Comprehensive Income | -0.1 | -1.4 | 1.3 | 2.4 | -1.7 | -0.9 | -0.7 | -2.0 | 0.3 | -1.3 | -0.4 | -1.5 | 0.9 | 1.1 | -19.4 | -17.7 | |
| Total Common Equity | 112.5 | 143.5 | 106.6 | 83.5 | 70.7 | 63.3 | 57.6 | 51.8 | 49.8 | 45.3 | 47.0 | 40.3 | 42.6 | 40.6 | 37.4 | 37.0 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Retained Earnings | 164.5 | 137.3 | 144.4 | 121.7 | 112.2 | 99.1 | 104.8 | 91.7 | 88.1 | 77.1 | |
| Comprehensive Income | 3.2 | 0.8 | -1.4 | -1.6 | -0.1 | -0.6 | 1.3 | 0.8 | 1.9 | 2.4 | |
| Total Common Equity | 168.1 | 138.5 | 143.5 | 120.5 | 112.5 | 98.9 | 106.6 | 93.0 | 90.5 | 79.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 57.1 | 102.8 | 27.0 | 25.8 | 26.6 | 10.4 | 4.5 | 0.5 | 1.7 | 0.2 | 1.1 | 0.7 | 0.2 | 0.5 | 0.9 | 2.2 | |
| Book Value | 112.5 | 143.5 | 106.6 | 83.5 | 70.7 | 63.3 | 57.6 | 51.8 | 49.8 | 45.3 | 47.0 | 40.3 | 42.6 | 40.6 | 37.4 | 37.0 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 168.1 | 138.5 | 143.5 | 120.5 | 112.5 | 98.9 | 106.6 | 93.0 | 90.5 | 79.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 89.9 | 102.4 | 101.0 | 83.7 | 55.5 | 47.8 | 42.1 | 39.0 | 38.6 | 38.1 | 37.9 | 34.9 | 26.5 | 25.2 | 21.4 | 17.1 | 14.4 | |
| Depreciation & Amortization | 17.3 | 14.7 | 8.5 | 9.4 | 7.4 | 6.0 | 5.8 | 5.7 | 3.9 | 3.2 | 3.2 | 3.0 | 3.4 | 2.8 | 2.7 | 0.0 | 2.5 | |
| Stock-Based Compensation | 2.1 | 0.0 | 2.3 | 2.1 | 1.5 | 1.0 | 0.8 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.0 | 0.0 | |
| Change Working Capital | 2.2 | 3.7 | -12.0 | -12.2 | -5.3 | -8.7 | -4.4 | -3.4 | -3.4 | -3.6 | -3.7 | -2.2 | -2.1 | -0.3 | 0.3 | 0.4 | 0.3 | |
| Change In Accounts Receivable | -14.2 | 0.0 | -14.3 | -14.2 | -9.9 | -12.9 | -2.8 | -2.1 | -2.6 | 0.1 | -4.7 | -2.4 | -2.1 | -1.3 | -0.3 | -0.8 | -1.9 | |
| Change In Accounts Payable | 10.0 | 0.0 | 3.2 | 10.0 | 6.7 | 3.2 | -0.6 | -0.4 | 1.1 | -0.4 | 1.1 | 0.0 | 0.9 | 0.2 | 0.6 | 0.4 | 1.8 | |
| Change In Inventories | -7.4 | 0.0 | -9.0 | -7.4 | -4.8 | -1.1 | -0.9 | -1.3 | -1.0 | -1.0 | -1.6 | -1.4 | -1.8 | 0.0 | -0.1 | 0.3 | 0.3 | |
| Other Non-cash Items | -2.1 | -1.7 | -5.1 | 4.9 | 6.3 | -2.5 | -3.4 | -4.4 | -4.0 | -7.4 | 0.7 | -6.4 | -4.1 | -9.5 | -8.9 | 3.8 | 2.6 | |
| Cash from Operations | 115.3 | 0.0 | 0.0 | 108.9 | 78.9 | 55.0 | 52.0 | 46.8 | 44.6 | 41.2 | 48.3 | 38.3 | 31.7 | 25.9 | 22.2 | 21.4 | 19.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 26.9 | 20.0 | 26.5 | 29.0 | 28.2 | 27.3 | 20.1 | 25.4 | 22.0 | 22.5 | |
| Depreciation & Amortization | 3.4 | 7.8 | 4.8 | 3.8 | 5.2 | 2.2 | 8.8 | 2.9 | 3.0 | 2.5 | |
| Stock-Based Compensation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 | |
| Change Working Capital | 20.4 | -5.0 | 4.8 | -16.4 | -1.0 | -11.3 | 9.9 | -9.6 | -9.7 | 11.7 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.2 | 0.0 | |
| Change In Accounts Payable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.4 | 0.0 | |
| Other Non-cash Items | -43.0 | 17.8 | -2.6 | 0.2 | -27.5 | 18.6 | 6.5 | -10.9 | -35.0 | 2.0 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.6 | 41.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -49.3 | -60.1 | -47.2 | -25.8 | -14.8 | -7.4 | -22.1 | -11.2 | -12.4 | -8.6 | -8.3 | -6.4 | -4.3 | -3.6 | -3.6 | -3.3 | -3.9 | |
| Acquisitions | 11.2 | 1.0 | -82.2 | 0.0 | -7.1 | -18.3 | -0.4 | -0.1 | 0.4 | 1.0 | 1.2 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | |
| Investments | -16.8 | -0.7 | -19.8 | -13.3 | -9.7 | -7.1 | 16.3 | -0.4 | -0.2 | 0.0 | -0.6 | -3.5 | 0.0 | 0.0 | -0.5 | 0.0 | -2.9 | |
| Sales of Investment | 22.0 | 10.7 | 24.4 | 8.3 | 6.6 | 1.2 | 0.0 | 0.1 | 0.2 | 2.1 | 2.1 | 1.5 | 2.2 | 0.8 | 0.0 | 0.0 | -0.5 | |
| Other Investing Activities | -9.0 | 0.0 | 0.0 | -13.1 | 0.0 | 0.0 | -16.2 | 0.0 | 0.0 | -1.0 | -1.2 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.5 | |
| Cash from Investing | -44.7 | 0.0 | 0.0 | -43.9 | -24.9 | -31.6 | -22.4 | -11.5 | -12.1 | -6.6 | -6.8 | -6.1 | -2.1 | -2.8 | -4.1 | -3.5 | -5.6 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -18.4 | -13.6 | -14.7 | -13.4 | -16.1 | -12.1 | -10.5 | -8.5 | -16.4 | -10.6 | |
| Acquisitions | 1.0 | 0.0 | 0.0 | 0.0 | -81.5 | 0.0 | 0.0 | 0.0 | 7.0 | 4.8 | |
| Investments | 0.0 | 0.0 | -0.6 | -0.1 | -0.4 | -8.4 | -9.9 | -1.2 | -0.9 | -4.8 | |
| Sales of Investment | 0.0 | 0.0 | 2.6 | 8.0 | 7.2 | 0.0 | 3.0 | 14.1 | 2.7 | 2.2 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.0 | -4.8 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.7 | -13.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -6.0 | 0.0 | 0.0 | -1.5 | -13.6 | -6.7 | -1.0 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -0.5 | 0.0 | |
| Debt Issued | 37.3 | 102.8 | 75.8 | 2.7 | 12.8 | 23.0 | 6.8 | 4.7 | -1.2 | 1.5 | -0.8 | 0.4 | 0.5 | -0.3 | 0.1 | -0.9 | 2.2 | |
| Issuance of Common Stock | 40.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | |
| Repurchase of Common Stock | -26.2 | -1.3 | -20.2 | -29.9 | -24.1 | -19.4 | -16.9 | -15.3 | -15.6 | -16.8 | -15.1 | -17.2 | -14.7 | -13.9 | -11.9 | -10.6 | -9.5 | |
| Dividends Paid | -42.0 | 0.0 | 0.0 | -31.8 | -25.3 | -21.5 | -20.1 | -19.4 | -19.0 | -18.8 | -23.8 | -12.9 | -11.9 | -9.7 | -7.7 | -5.7 | -4.4 | |
| Other Financing Activities | -6.4 | 0.0 | 0.0 | 0.0 | 11.2 | 22.2 | 5.7 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | -39.6 | 0.0 | 0.0 | -63.2 | -51.8 | -25.5 | -32.2 | -35.5 | -34.5 | -35.7 | -38.9 | -30.1 | -26.5 | -23.6 | -20.1 | -16.8 | -13.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -0.3 | |
| Debt Issued | 0.0 | 99.3 | -19.5 | 15.9 | 45.8 | -0.1 | 30.1 | -0.1 | 0.8 | 1.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -1.4 | -7.5 | -2.4 | -7.4 | -2.8 | -9.8 | -6.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.4 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10.1 | -19.8 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 31.2 | 10.8 | 1.3 | 1.7 | 1.9 | -1.5 | -3.2 | -0.2 | -1.5 | -1.3 | 2.6 | 2.2 | 3.2 | -0.5 | -2.0 | 1.1 | 0.9 | |
| Closing Cash Balance | 52.8 | 26.5 | 15.7 | 14.4 | 12.7 | 10.7 | 12.2 | 15.4 | 15.6 | 17.2 | 18.5 | 15.9 | 13.7 | 10.5 | 11.1 | 13.1 | 12.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -5.6 | 13.6 | -20.5 | 23.3 | -41.4 | 4.2 | 46.5 | -8.1 | -15.5 | 8.3 | |
| Closing Cash Balance | 26.5 | 32.1 | 18.4 | 38.9 | 15.7 | 57.0 | 52.8 | 6.3 | 14.4 | 29.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 66.0 | 29.0 | 69.7 | 70.0 | 64.1 | 47.6 | 29.9 | 35.6 | 32.2 | 32.5 | 40.0 | 31.9 | 27.4 | 22.3 | 18.6 | 18.0 | 15.8 | |
| Real Free Cash Flow | 63.9 | 29.0 | 67.4 | 67.9 | 62.6 | 46.6 | 29.0 | 35.2 | 31.8 | 32.2 | 39.7 | 31.4 | 27.0 | 21.9 | 18.3 | 18.0 | 15.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.8 | 32.5 | 24.5 | 10.0 | -4.3 | 31.7 | 37.3 | 5.3 | -6.9 | 30.3 | |
| Real Free Cash Flow | -10.8 | 32.5 | 24.5 | 10.0 | -4.3 | 31.7 | 37.3 | 5.3 | -9.0 | 30.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 2.1 | 2.8 | 86.1 |
| P/S | 0.7 | 0.9 | 578 |
| P/B | 1.3 | 1.9 | 582.9 |
| P/FCF | 3.9 | 3.1 | 10581.1 |
| Market cap | $203.1 | $318.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 4.8 % | 0 % |
| Debt to Income | 97.1 % | 20.3 % | 0 % |
| Debt to Free cash flow | 176.7 % | 3321.4 % | 0 % |
| Interest expense percentage | 5.1 % | 2.4 % | 0 % |
| Current ratio | 0.8 | 1.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 60.8 % | 66.8 % | 0 % |
| ROA | 21.2 % | 29.8 % | 0 % |
| CapEx to Revenue | 19.5 % | 9 % | 0 % |
| RaD to Revenue | 0 % | 13.3 % | 0 % |
| ROEM | 4,111,397.5 | 2136913.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 81 % | 83.4 % | 0 % |
| Operating margin | 41.4 % | 40.5 % | 0 % |
| Net margin | 33.1 % | 31.5 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 22.2 % | 0 % |
| Dividend payout percentage | 0 % | 51.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 4,447.9 mil | 3,162.5 mil |
| Employee count | 75.0 tis | 34.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
